Acute mountain sickness and high altitude cerebral and pulmonary edema;Mal aigu dec montagnes et œdème cérébral de haute altitude

Revue du Praticien

Volumn 63, Issue 1, 2013, Pages 18-26

  Kedzierewicz, Romain ^a   Cabane, Damien ^a  

^a Centre Médical des Armées des Alpes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ACETYLSALICYLIC ACID; DEXAMETHASONE; IBUPROFEN; SUMATRIPTAN;

ACUTE DISEASE; ALTITUDE DISEASE; ARTICLE; BRAIN EDEMA; FATALITY; HYPOXIA; LUNG EDEMA; PATHOPHYSIOLOGY; ALTITUDE; HUMAN; PULMONARY HYPERTENSION; REVIEW;

ACUTE DISEASE; ALTITUDE; ALTITUDE SICKNESS; BRAIN EDEMA; HUMANS; HYPERTENSION, PULMONARY;

MLCS; MLOWN;

EID: 84873643850     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Bauer IL Travel health advice as recalled by 552 tourists to Peru. J Travel Med 2002;9:293-6.
2. Vardy J, Vardy J, Judge K. Can knowledge protect against acute mountain sickness. J Pub Health 2005;27:336-70.
3. The Lake Louise consensus on the definition and quantification of altitude illness. In. Sutton JR, Coates G, Houston CS, editors. Hypoxia and Mountain Medicine. Burlington: Queen City Printers, 1992:327-30.
4. Pichler J, Risch L, Hefti U, et al. Glomerular filtration rate estimates decrease during high altitude expedition but increase with Lake Louise acute mountain sickness scores. Acta Physiol 2008, 192:443-50.
5. Hackett PH, Rennie D. The incidence, importance, and prophylaxis of acute mountain sickness. Lancet 1976;2:1149-55.
6. Kayser B, Aliverti A, Pellegrio R, et al. Comparison of visual analogue scale and lake Louise symptom scores for acute mountain sickness. High Alt Med Biol 2010;11:69-72.
7. Meijer HJ, Jean D. Children at altitude. Consensus statement of the UIAA medical commission 2008, 9:1-14
8. Wu T, Ding S, Liu J, et al. Ataxia: an early indicator in high altitude cerebral edema. High Alt Med Biol 2006, 7:275-80.
9. Mairer K, Wille M, Bûcher T, Burtscher M. Prevalence of acute mountain sickness in the Eastern Alps High Alt Med Biol 2009;10:239-45.
10. Mairer K, Wille M, Burtscher M. The prevalence of and risk factors for acute mountain sickness in the eastern and western Alps. High Alt Med Biol 2010;11:343-8.
11. Ren T, Fu Z, Shen W, et al. Incidence of high altitude illnesses among unacclimatized persons who acutely ascended to Tibet. High Alt Med Biol 2011;11:39-42.
12. Wu TY, Ding SQ, Liu JL, et al. Smoking, acute mountain sickness and altitude acclimatation: a cohort study. Thorax 2012. [Epub ahead of print].
13. Richalet JP, Larmignat P, Poitrine E, Letoumel M, Canouï-Poitrine F. Physiological risk factors of severe altitude illness: a prospective cohort study. Am J Respir Crit Care Med 2012;185:192-8.
14. Rexhaj E, Garcin S, Rimoldi SF, et al. Reproducibility of acute mountain sickness in children and adults: a prospective study. Pediatrics 2011;127:e1445-8.
15. Bailey DM, Evans KA, James PE, et al. Altered free radical metabolism in acute mountain sickness implications for dynamic cerebral autoregulation and blood-barrier function. J Physiol 2009;587:73-85.
16. Kallenberg K, Bailey DM, Christ S, et al. Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness. J Cereb Blood Flow Metab 2007;27:1064-71.
17. Schoonman GG, Sandor PS, Nirkko AC, et al. Hypoxiainduced acute mountain sickness is associated with intracellular edema, a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab 2008;28:198-206.
18. Bailey DM, Bartsch P, Knauth M, Baumgartner RW. Emerging concepts in acute mountain sickness and highaltitude cerebral edema: from the molecular to the morphological. Cell Mol Life Sci 2009;66:3583-94.
19. Yu Z, Liu N, Wang Y, Li X, Wang X. Identification of neuroglobin- interacting proteins using yeast two-hybrid screening. Neuroscience 2012;200 99-105.
20. Messlinger K. Migraine: where and how does the pain originate? Exp Brain Res 2009;196:179-93.
21. Wilson MH, Edsell ME, Davagnanam I, et al. Cerebral artery dilatation maintains cerebral oxygenation at extreme altitude and in acute hypoxia. An ultrasound and MRI study. J Cereb Blood Flow Metab 2011, 31 2019-29.
22. Kallenberg K, Dehnert C, Dôrfler A, et al. Microhemorrhages in nonfatal high-altitude cerebral edema. J Cereb Blood Row Metab 2008;28:1635-42.
23. Luks AM, McIntosch SE, Grissom CK, et al. Wilderness medical society consensus guidelines for the prevention and treatment of acute altitude illness. Wilderness Environ Med 2010, 21:146-55.
24. Beaumont M, Batéjat D, Piérard C, et al. Zalepon and Zolpidem objectively alleviate sleep disturbances in mountaineers at a 3, 613 meter altitude. Sleep 2007;30:1527-33
25. Macnutt MJ, Laursen PB, Kedia S et al. Acclimatisation in trekkers with and without recent exposure to high altitude. Eur J Appl Physiol 2012;112:3287-94.
26. Muza SR, Beidleman BA, Fulco CS. Altitude preexposure recommendations for inducing acclimatization. High Alt Med Biol 2010;11:87-92.
27. Richardson A, Watt P, Maxwell N. Hydration and physiological responses to acute normobaric hypoxia. Wilderness Environ Med 2009;20:212-20.
28. Tissot Van Patot MC, Leadbetter G 3rd, Keyes LE, Maakestad KM, Olson S, Hackett PH. Prophylactic lowdose acetazolamide reduces the incidence and severity of acute mountain sickness. High Alt Med Biol 2008;9:289-93
29. Luks AM, Swenson ER. Medication and dosage considerations in the prophylaxis and treatment of high altitude illness. Chest 2008;133:744-55.
30. Burtscher M, Likar R, Nachbauer W, Ptiiladelphy M. Aspirin (or prophylaxis against headache at high altituderandomised, double blind, placebo controlled trial. BMJ 1998;316:1057-8.
31. Burtscher M, Likar R, Nachbauer W, Ptiiladelphy M, Pùhringer R, Lämmle T. Effects of aspirin during exercise on the incidence of high-altitude headache, a randomized, double-blind, placebo-controlled trial. Headache 2001:41. 542-5.
32. Kayser B, Hulsebosch R, Bosch F. Low-dose acetyl salicylic acid analog and acetazolamide for prevention ot acute mountain sickness. High Alt Med Biol 2008;9. 15-23.
33. Lipman GG, Kanaan NC, Hoick PS, Constance BB, Gertsch JH. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories. Ann Emerg Med 2012, 59484-90
34. Gertsch JH, Lipman GS, Hoick PS, et al. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against High altitude headache: the headache evaluation at altitude trial (HEAT). Wilderness Environ Med 2010, 21:236-43.
35. Jafarian S, Gorouhi F, Salimi S, Lotfi J. Sumatriptan for prevention of acute mountain sickness: randomized clinical trial. Ann Neurol 2007;62:273-7.
36. Bates MG, Thompson AA, Baillie JK, et al. Sildenafil citrate for the prevention of High altitude hypoxic pulmonary hypertension: double blind, randomized, placebo-controlled trial. High Alt Med Biol 2011;12 207-14.
37. Leadbetter G, Keyes LE, Maakestad KM, Olson S, Tissot Van Patot MC, Hackett PH. Ginkgo biloba does and does not prevent acute mountain sickness. Wilderness Environ Med 2009, 20-66-71.
38. Baillie JK, Thompson AA, Irving JB, et al. Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized, placebo-controlled trial. QJM 2009;102:341-8.
39. Küpper TH, Gieseler U, Milledge J. Portable hyperbaric Chambers. Consensus statement of the UIAA medical commission 2008;3:1-7.
40. Bärtsch P, Merki B, Hostetter D, Maggiorini M, Kayser B, Oelz O. Treatment of acute mountain sickness by simulated descent: a randomised controlled trial. BMJ 1993;306:1098-101.
41. Keller HR, Maggiorini M, Bärtsch P, Oelz O. Simulated descent vs dexamethasone in treatment of acute mountain sickness-a randomised trial. BMJ 1995, 310:1232-5